Trial Profile
Management of Patients With Moderate to Severe Asthma Uncontrolled When Treated With Low Dose Inhaled Corticosteroids: Cost-Effectiveness of Three Therapeutics Alternatives
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2009
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary) ; Beta 2 adrenergic receptor agonists; Corticosteroids
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 15 Jul 2009 New trial record